Home Clinical trials Diprivan™ (propofol)
|
|
| Diprivan™ (propofol) Clinical Trial report summaries |
Diprivan™ (propofol) is an injectable general anaesthetic for the induction and maintenance of anaesthesia Diprivan™ (propofol) is also approved in most markets for use in the sedation of mechanically ventilated intensive care adult patients and the sedation of patients undergoing diagnostic or surgical procedures.
Please consult the prescribing information for the country concerned for guidance on the approved use of Diprivan™ (propofol). | Study Number | Completed Clinical Trial Report Summaries | 0859IL/0068 | A Multicenter, Comparative, Randomized Trial to Determine the Overall Safety and Efficacy of 1% Diprivan] vs 2% Diprivan vs Standard Agents Without Disodium Edetate for Sedation of Trauma, Postsurgical, or Critically Ill Pediatric Subjects. |
|
|
|
|